These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 12315)
1. Change of dissolution rate profile of salicylamide in caffeine complexing medium [proceedings]. Donbrow M; Touitou E J Pharm Pharmacol; 1976 Dec; 28 Suppl():4P. PubMed ID: 12315 [No Abstract] [Full Text] [Related]
2. Effect of processing technique of different dosage forms on dissolution rate of caffeine and salicylamide. Nerlo H; Czarnecki W; Dul R Pol J Pharmacol Pharm; 1976; 28(4):361-7. PubMed ID: 981026 [TBL] [Abstract][Full Text] [Related]
3. Estimation of dissolution rate of salicylamide in complexing media using a theoretical diffusion model. Donbrow M; Touitou E J Pharm Sci; 1978 Jan; 67(1):95-8. PubMed ID: 619122 [TBL] [Abstract][Full Text] [Related]
4. Dissolution rates of caffeine and salicylamide from tablets. Nerlo H; Czarnecki W; Dul R Pol J Pharmacol Pharm; 1974; 26(5):549-53. PubMed ID: 4427817 [No Abstract] [Full Text] [Related]
5. The dissolution mechanism in a system undergoing complexation: salicylamide in caffeine solution. Donbrow M; Touitou E J Pharm Pharmacol; 1977 Sep; 29(9):524-8. PubMed ID: 21254 [TBL] [Abstract][Full Text] [Related]
6. Studies of the thermodynamics of dissolution, solubilization and micellar binding of salicylamide by a nonionic surfactant. Biber MZ; Rhodes CT Acta Pharm Suec; 1974 Jun; 11(3):275-82. PubMed ID: 4839737 [No Abstract] [Full Text] [Related]
7. Dissolution kinetics of a three-component solid II: benzoic acid, salicylic acid, and salicylamide. Parrott EL; Simpson M; Flanagan DR J Pharm Sci; 1983 Jul; 72(7):765-8. PubMed ID: 6886982 [TBL] [Abstract][Full Text] [Related]
8. Dissolution kinetics of a three-component solid I: ethylparaben, phenacetin, and salicylamide. Simpson M; Parrott EL J Pharm Sci; 1983 Jul; 72(7):757-64. PubMed ID: 6886981 [TBL] [Abstract][Full Text] [Related]
9. Stability of salicylamide-caffeine complex at different temperatures and its thermodynamic parameters. Donbrow M; Touitou E; Shalom HB J Pharm Pharmacol; 1976 Oct; 28(10):766-9. PubMed ID: 10371 [TBL] [Abstract][Full Text] [Related]
10. [The influence of caffeine on the analgesic effects of salicylamide]. Lippert TH; Samaha M Arzneimittelforschung; 1965 Sep; 15(9):1079-80. PubMed ID: 5898696 [No Abstract] [Full Text] [Related]
11. Hydrolysis kinetics of 1,3-benzoxazine-2,4-dione (a potential salicylamide prodrug) and various N-substituted derivatives. Kahns AH; Bundgaard H Acta Pharm Nord; 1991; 3(1):45-50. PubMed ID: 1854435 [TBL] [Abstract][Full Text] [Related]
12. Effect of complex formation on drug absorption. IX. Determination of the intestinal transfer rate constant of the salicylamide-caffeine complex. Reuning RH; Levy G J Pharm Sci; 1969 Jan; 58(1):79-83. PubMed ID: 5765843 [No Abstract] [Full Text] [Related]
13. Inhibitory effects of salicylate on contractility in skeletal muscle. Suarez-Kurtz G; Braga da Costa MJ; Coutinho S J Pharmacol Exp Ther; 1984 Aug; 230(2):478-82. PubMed ID: 6431080 [TBL] [Abstract][Full Text] [Related]
14. Gas-liquid chromatographic assay for salicylamide, acetaminophen, and caffeine mixtures, using on-line, computerized real-time data acquisition. Alber LL; Overton MW; Smith DE J Assoc Off Anal Chem; 1971 May; 54(3):620-4. PubMed ID: 5162923 [No Abstract] [Full Text] [Related]
15. Estimation of the molecular weight of an interacting chlorpheniramine maleate-salicylamide system from dissolution rate data. Shah SP; Flanagan DR J Pharm Sci; 1994 Jan; 83(1):113-4. PubMed ID: 8138899 [No Abstract] [Full Text] [Related]
16. Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study. Pang KS; Barker F; Schwab AJ; Goresky CA J Pharmacol Exp Ther; 1994 Jul; 270(1):285-95. PubMed ID: 8035326 [TBL] [Abstract][Full Text] [Related]
17. [Dissolution rate of the organic raw materials of drugs. II]. Reisner E; Nikolics K Acta Pharm Hung; 1983 Nov; 53(6):256-67. PubMed ID: 6666588 [No Abstract] [Full Text] [Related]
18. Dissolution characteristics of cylindrical particles and tablets. Fukunaka T; Yaegashi Y; Nunoko T; Ito R; Golman B; Shinohara K Int J Pharm; 2006 Mar; 310(1-2):146-53. PubMed ID: 16414218 [TBL] [Abstract][Full Text] [Related]
19. Availability studies on acetylsalicylic acid, salicylamide and phenacetin at different pH values. el-Sourady HA; Habib FS; Mohamed SI Pharmazie; 1985 Sep; 40(9):639-41. PubMed ID: 4070347 [TBL] [Abstract][Full Text] [Related]
20. [Separation and identification of components of drugs containing salicylamide by means of paper chromatography]. Fecko J; Przybylek-Piontek W Acta Pol Pharm; 1968; 25(2):177-81. PubMed ID: 5662910 [No Abstract] [Full Text] [Related] [Next] [New Search]